Newer Treatments for Acute Lymphoblastic Leukemia

Discover how newer therapies for acute lymphoblastic leukemia (ALL) offer patients hope. Learn about the benefits of targeted treatments like Besponsa, glembatumumab and Blincyto.

Key Points:

- Reduced side effects compared to traditional chemotherapy
- Improved tolerability for older patients
- Targeted therapy for cancer cells

Watch the full interview with Dr. Hannah Levavi to better understand these innovative treatments and their potential impact on patient outcomes.

#acutelymphoblasticleukemia #ALL #cancer #cancertreatment #newtreatments #cancerresearch #cancerawareness #health #healthcare #medicine #oncology #hematology

Or visit out socials!


CURE® has become the largest consumer magazine in the United States focused entirely on cancer. With a total circulation of 285,000, individual subscribers account for over 140,000 of that figure, with the remainder including cancer centers and advocacy groups around the country. CURE®’s time-tested approach combines science, humanity and technology to make cancer understandable for patients and their caregivers.

Image Credit: Adobe Stock